Your browser doesn't support javascript.
loading
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
Fujioka, Isao; Takaku, Tomoiku; Iriyama, Noriyoshi; Tokuhira, Michihide; Kimura, Yuta; Sato, Eriko; Ishikawa, Maho; Nakazato, Tomonori; Sugimoto, Kei-Ji; Fujita, Hiroyuki; Asou, Norio; Kizaki, Masahiro; Hatta, Yoshihiro; Komatsu, Norio; Kawaguchi, Tatsuya.
  • Fujioka I; Department of Hematology, Juntendo University School of Medicine, 3-1-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Takaku T; Department of Hematology, Juntendo University School of Medicine, 3-1-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. ttakaku@juntendo.ac.jp.
  • Iriyama N; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Tokuhira M; Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Kimura Y; Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Sato E; Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan.
  • Ishikawa M; Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.
  • Nakazato T; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
  • Sugimoto KJ; Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan.
  • Fujita H; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.
  • Asou N; Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.
  • Kizaki M; Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Hatta Y; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Komatsu N; Department of Hematology, Juntendo University School of Medicine, 3-1-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Kawaguchi T; Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan.
Ann Hematol ; 97(11): 2081-2088, 2018 Nov.
Article en En | MEDLINE | ID: mdl-29946911

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Infarto Cerebral / Isquemia Miocárdica / Inhibidores de Proteínas Quinasas / Enfermedad Arterial Periférica Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Infarto Cerebral / Isquemia Miocárdica / Inhibidores de Proteínas Quinasas / Enfermedad Arterial Periférica Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article